Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Siemens Unveils New Chemistry and Immunoassay Systems

Published: Thursday, July 31, 2014
Last Updated: Thursday, July 31, 2014
Bookmark and Share
Company introduces the ADVIA Chemistry XPT and ADVIA Centaur XPT Immunoassay System at AACC 2014.

Siemens Healthcare has introduced the ADVIA Chemistry XPT System and ADVIA Centaur XPT Immunoassay System at the 2014 AACC Annual Meeting and Clinical Lab Expo, Chicago, July 27-31.

The newest in the company’s portfolio of chemistry and immunoassay instruments for the central laboratory, these systems are designed to enable continuous and simple operation, facilitate delivery of high quality, rapid results, and work seamlessly with automation in high-volume laboratories.

“Faced with ever-increasing workload demands, our customers need easy-to-use solutions that enhance workflow and quickly provide the results,” said Franz Walt, CEO, Chemistry, Immunoassay, Automation and Diagnostics IT Business Unit, Diagnostics Division, Siemens Healthcare. “The ADVIA Chemistry XPT System and ADVIA Centaur XPT Immunoassay System are new central laboratory analyzers designed to meet these requirements.”

Each system features versatile technology that will enable a broad range of testing to assist clinicians in disease screening, diagnosing and monitoring. Additionally, easy operation will be supported with harmonized, intuitive software, large touchscreens and Siemens Remote Service diagnostics.

A fast system for the high-volume laboratory with a throughput of up to 2400 tests per hour, the ADVIA Chemistry XPT System achieves predictable turnaround times through a combination of micro-volume technology and aliquot retention.

Sample aliquots are readily available onboard for testing and retesting; there is no need to return the tube to the system. The system also includes VeriSmart Technology, a combination of hardware and software checks to help ensure high-quality results.

The ADVIA Centaur XPT Immunoassay System is designed to process up to 240 tests per hour, upload test definitions on demand, and provide uninterrupted processing even when loading and unloading samples, reagents and supplies. The system is intended to require very little maintenance. Its user interface features powerful, easy-to-use software with extensive data management capabilities, and intelligent software algorithms are designed to support laboratory management of results by automatically providing effective diagnostic testing strategies.

Both systems are automation-ready, and can be connected to Siemens’ Aptio Automation, the company’s latest track-based automation system. They require no additional robotics, and utilize point-in-space technology which allows for sampling directly from the automation track.

Also, the ADVIA Chemistry XPT System and ADVIA Centaur XPT Immunoassay System can be connected to the company’s CentraLink Data Management System, which streamlines workflow across automation, IT and instruments, and Siemens Remote Service (SRS).


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
New Diagnostic Tool for Familial Mediterranean Fever
A new tool developed by researchers at VIB and Ghent University could improve the process of diagnosing Familial Mediterranean Fever.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Molecular Signature for Aggressive Brain Tumor Uncovered
Researchers have identified genetic mutations in a highly agressive brain cancer that distinguishes the agressive, from the benign forms of the cancer.
Malaria Parasite Evades Rapid Test Detection in Children
A study at the University of North Carolina found that gene deletion poses a threat to Malaria eradication efforts.
Novel Urine Test to Predict High-Risk Cervical Cancer
Preliminary studies affirm accuracy and potential cost savings to screen for virus-caused malignancy.
GFC Diagnostics Wins Longitude Prize Discovery Award
The global award was won for the development of a cheap, quick and simple MRSA Test.
Understanding Circulating Tumour Cells
Research team develops new tool to track traveling cancer cells in the bloodstream.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!